The revenue growth rate in Q4 2023 was 37% year-over-year, the highest recorded growth rate since 2003.
The CEO's comment that growth can be sustained despite competition is a strong forward-looking statement by Novo Nordisk that cements its position as the most valuable company in Europe.
[
add
]
[
|
|
...
]